publication venue for
- [Gene therapy – from idea to reality].. 114:EWYL. 2017
- [Bleeding time--only in special cases. The method is of little value as a general screening analysis].. 105:1268. 2008
- [Wrong focus in the debate on burnout].. 104:2446. 2007
- [Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer].. 101:1712-1715. 2004
- [There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis].. 100:2118-2121. 2003
- [Cure of hemophilia is approaching. Gene therapy is the hope].. 98:5454-5457. 2001
- [Prothromplex in stead of Beriplex P/N as acute antidote against warfarin].. 98:3807. 2001
- [Venous thromboembolism, warfarin and cancer--a well-known connection].. 97:4554. 2000
- [Length of treatment in deep venous thrombosis--some comments].. 97:862-864. 2000
- [Centralized care is the basis of care programs for hemophilia patients].. 96:1849-1852. 1999
- [Increased risk of thrombosis in FXII deficiency?].. 92:425. 1995
- [Desmopressin--an effective agent in many hemorrhagic disorders].. 89:4155-4158. 1992
- [Recurrent infections should be investigated with consideration to primary immunodeficiency].. 89:2593-2597. 1992
- [New preparations for coagulation disorders].. 89:2430. 1992
- [Difficulties in obtaining financial support for studies of hemorrhage during treatment with anticoagulants].. 86:1354. 1989
- [Elimination of antibodies against coagulation factor VIII: Factor VIIa is the most promising therapeutic alternative].. 86:219-221. 1989
- [Hereditary thrombogenic defects in the national family registry].. 84:1251-1253. 1987